Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy.
about
Prognostic factors in hodgkin lymphomaFDG PET/CT imaging as a biomarker in lymphoma.Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients.Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma.
P2860
Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Tumour burden predicts treatme ...... ed with ABVD and radiotherapy.
@en
Tumour burden predicts treatme ...... ed with ABVD and radiotherapy.
@nl
type
label
Tumour burden predicts treatme ...... ed with ABVD and radiotherapy.
@en
Tumour burden predicts treatme ...... ed with ABVD and radiotherapy.
@nl
prefLabel
Tumour burden predicts treatme ...... ed with ABVD and radiotherapy.
@en
Tumour burden predicts treatme ...... ed with ABVD and radiotherapy.
@nl
P2093
P2860
P50
P356
P1476
Tumour burden predicts treatme ...... ted with ABVD and radiotherapy
@en
P2093
Chiara Coriani
Emilio Bassi
Emilio Iannitto
Giuseppe Polimeno
Manuela Bergonzi
Paolo G Gobbi
P2860
P304
P356
10.1002/HON.1024
P577
2012-01-23T00:00:00Z